Health ❯ Healthcare

Autoimmune Diseases

Lupus Rheumatoid Arthritis Type 1 Diabetes Systemic Lupus Erythematosus Psoriasis Treatment Strategies Multiple Sclerosis Dermatomyositis Vasculitis Research

Regulators Move to Strip Approval of Tavneos After Trial Misconduct and Liver Safety Signals

The move could remove Tavneos from markets, upend care for current patients, increase scrutiny of clinical trial oversight.

FDA Grants Priority Review to Roche’s Enspryng for Thyroid Eye Disease

FDA Approves Lumvoa for Thyroid Eye Disease

EMA Committee Recommends Revoking Tavneos Authorization

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

Kissei Tells Japan Doctors to Halt New Tavneos Use After 20 Deaths Reported

UCB to Buy Candid Therapeutics for Up to $2.2 Billion

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

FDA Clears Once-Weekly Saphnelo Pen for Self-Injection in Lupus

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

CAR-T Therapy Puts Three Autoimmune Diseases Into Sustained Remission in One Patient

Butantan Strikes Deal to Make CAR-T in Brazil as New Case Points to Wider Uses

Single CAR-T Infusion Puts Three Severe Autoimmune Diseases in Remission

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

NEJM Publication Confirms Phase 3 Win for Brepocitinib in Dermatomyositis

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

MHRA Approves Leqselvi for Severe Alopecia Areata in Adults

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March